TDT
Showing 1 - 25 of 90
Avoidance of Futile Excisions Through Skin Tele-triage
Enrolling by invitation
- Melanoma (Skin)
- Telemedicine
- Single Assessor Teledermatological triage (TDT)
- +3 more
-
Brønshøj, Copenhagen, DenmarkGustav Gede Nervil
Aug 1, 2023
Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)
Recruiting
- Transfusion Dependent Beta Thalassemia
- +3 more
- EDIT-301
-
Oakland, California
- +3 more
Jan 3, 2023
Rectal Cancer, Anastomotic Leak Trial (removal of transanal drainage tube)
Not yet recruiting
- Rectal Cancer
- Anastomotic Leak
- removal of transanal drainage tube
- (no location specified)
Aug 12, 2022
Trans Pedicular Screw Fixation of The Sub-axial Cervical Spine
Not yet recruiting
- Pedicle Screw
- CPS
- (no location specified)
May 4, 2023
Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)
Active, not recruiting
- Transfusion Dependent Beta-thalassemia
- ST-400 Investigational product
-
Los Angeles, California
- +5 more
Jul 6, 2022
Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))
Recruiting
- Transfusion Dependent Beta-Thalassemia
- GMCN-508B (LentiRed)
-
Nanning, Guangxi, ChinaThe affiliated hospital of guangxi medical university
Feb 28, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Anastomotic Leakage, Rectal Tumors Trial in Chongqing (with TDT, without TDT)
Completed
- Anastomotic Leakage
- Rectal Neoplasms
- with TDT
- without TDT
-
Chongqing, Chongqing, ChinaDaping hospital
May 4, 2021
Stroke, Swallowing Disorder, Dysphagia Trial in Istanbul (Procedure: Traditional Dysphagia Therapy (TDT), Procedure:
Active, not recruiting
- Stroke
- +4 more
- Procedure: Traditional Dysphagia Therapy (TDT)
- Procedure: Neuromuscular Electrical Stimulation with TDT
-
Istanbul, Fatih, TurkeyIstanbul University Istanbul Faculty of Medicine, Department of
Nov 1, 2021
Transfusion-dependent Beta-thalassemia After Gene Therapy
Recruiting
- Transfusion-dependent Beta-Thalassemia
- Gene Therapy
- Gene therapy
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Aug 6, 2023
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)
Recruiting
- Transfusion-dependent Thalassemia
- Thalidomide Capsules
- Placebo
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Oct 18, 2023
Gingival Recession, Palate; Wound Trial in Milan, Piacenza (DGG Harvesting approach, ET harvesting approach, TDT harvesting
Completed
- Gingival Recession
- Palate; Wound
- DGG Harvesting approach
- +4 more
-
Milan, Italy
- +1 more
Jun 29, 2020
Oxidative Stress and Iron Overload in Abnormal Haemoglobinopathy
Not yet recruiting
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- (no location specified)
Oct 16, 2022
MCI Speech in Noise
Not yet recruiting
- Mild Cognitive Impairment
- (no location specified)
Oct 24, 2023
ß-thalassemia Trial (BD211)
Not yet recruiting
- β-thalassemia
- BD211
- (no location specified)
Mar 15, 2023
ß-thalassemia Trial in Shanghai (BD211)
Not yet recruiting
- β-thalassemia
- BD211
-
Shanghai, ChinaShanghai Ruijin Hospital
Mar 16, 2023
Anti-SARS-CoV-2 and Encapsulated Vaccination Thalassemic and
Recruiting
- SARS-CoV-2 Infection, Thalasemmie, SCD
-
Torino, TO, Italy
- +8 more
Feb 1, 2022
Hematologic Diseases Trial in Kunming (BD211 Drug Product)
Enrolling by invitation
- Hematologic Diseases
- BD211 Drug Product
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Aug 14, 2021
Non-syndromic Retinitis Pigmentosa Trial in Pittsburgh, Paris, London (Gene therapy: GS030-DP AND Medical device: GS030-MD)
Recruiting
- Non-syndromic Retinitis Pigmentosa
- Gene therapy: GS030-DP AND Medical device: GS030-MD
-
Pittsburgh, Pennsylvania
- +2 more
Jul 25, 2022
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
HER2-ve Metastatic Breast Cancer, Germline BRCA1/2 Mutations, Somatic BRCA1/2 Mutations Trial in Worldwide (Olaparib)
Completed
- HER2-ve Metastatic Breast Cancer
- +2 more
-
Towson, Maryland
- +122 more
Dec 22, 2022